150 related articles for article (PubMed ID: 12497921)
1. [Long-QT caused by drugs and torsade de pointes: a genetic basis?].
Schwartz PJ
Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):277-9. PubMed ID: 12497921
[No Abstract] [Full Text] [Related]
2. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
[TBL] [Abstract][Full Text] [Related]
3. Amiodarone-associated macroscopic T-wave alternans and torsade de pointes unmasking the inherited long QT syndrome.
Wegener FT; Ehrlich JR; Hohnloser SH
Europace; 2008 Jan; 10(1):112-3. PubMed ID: 18006559
[No Abstract] [Full Text] [Related]
4. Drug-induced QT-interval prolongation and recurrent torsade de pointes in a child with heterotaxy syndrome and KCNE1 D85N polymorphism.
Lin L; Horigome H; Nishigami N; Ohno S; Horie M; Sumazaki R
J Electrocardiol; 2012; 45(6):770-3. PubMed ID: 22999324
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced long QT and torsade de pointes: recent advances.
Kannankeril PJ; Roden DM
Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced long QT syndrome and Torsade de Pointes.
Chism S; Smith E
J Ark Med Soc; 2004 Jul; 101(1):24-6. PubMed ID: 15270138
[No Abstract] [Full Text] [Related]
8. [Preclinical evaluation of drug induced QT prolongation].
Hashimoto K
Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):408-10. PubMed ID: 12899128
[No Abstract] [Full Text] [Related]
9. Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome.
Weeke P; Mosley JD; Hanna D; Delaney JT; Shaffer C; Wells QS; Van Driest S; Karnes JH; Ingram C; Guo Y; Shyr Y; Norris K; Kannankeril PJ; Ramirez AH; Smith JD; Mardis ER; Nickerson D; George AL; Roden DM
J Am Coll Cardiol; 2014 Apr; 63(14):1430-7. PubMed ID: 24561134
[TBL] [Abstract][Full Text] [Related]
10. [Drug-induced long QT syndrome and torsade de pointes arrhythmias].
Dhein S
Dtsch Med Wochenschr; 2000 Jun; 125(22):703-8. PubMed ID: 10874898
[No Abstract] [Full Text] [Related]
11. Torsade de pointes: the clinical considerations.
Gowda RM; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
Int J Cardiol; 2004 Jul; 96(1):1-6. PubMed ID: 15203254
[TBL] [Abstract][Full Text] [Related]
12. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
Mok NS; Lo YK; Tsui PT; Lam CW
J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
[TBL] [Abstract][Full Text] [Related]
13. [Adverse drug reactions. QT-prolongation and torsade-de-pointes arrhythmias].
Haffner S; Lapp H; Thürmann PA
Dtsch Med Wochenschr; 2002 May; 127(19):1022-4. PubMed ID: 11997870
[No Abstract] [Full Text] [Related]
14. Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics.
Calderone V; Testai L; Martinotti E; Del Tacca M; Breschi MC
J Pharm Pharmacol; 2005 Feb; 57(2):151-61. PubMed ID: 15720777
[TBL] [Abstract][Full Text] [Related]
15. Cardiac channelopathies: it's in the genes.
Ackerman MJ
Nat Med; 2004 May; 10(5):463-4. PubMed ID: 15122246
[No Abstract] [Full Text] [Related]
16. Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.
Shah RR
Drug Saf; 2004; 27(3):145-72. PubMed ID: 14756578
[TBL] [Abstract][Full Text] [Related]
17. [Long QT and torsades de pointes as adverse effects of drugs].
Jensen K
Ugeskr Laeger; 2000 Oct; 162(42):5654. PubMed ID: 11059311
[No Abstract] [Full Text] [Related]
18. Genetics of acquired long QT syndrome.
Roden DM; Viswanathan PC
J Clin Invest; 2005 Aug; 115(8):2025-32. PubMed ID: 16075043
[TBL] [Abstract][Full Text] [Related]
19. QT interval prolongation and torsade de pointes associated with indapamide. Comments to Letsas et al.
Perciaccante A; Fiorentini A
Int J Cardiol; 2007 Nov; 122(3):255; author reply 256-7. PubMed ID: 17368589
[No Abstract] [Full Text] [Related]
20. Psychotropic drugs, torsade de pointes and sudden death.
Taylor D
Acta Psychiatr Scand; 2005 Mar; 111(3):169-70. PubMed ID: 15701099
[No Abstract] [Full Text] [Related]
[Next] [New Search]
